143 related articles for article (PubMed ID: 18640726)
1. Characterisation of soluble murine CD137 and its association with systemic lupus.
Shao Z; Sun F; Koh DR; Schwarz H
Mol Immunol; 2008 Sep; 45(15):3990-9. PubMed ID: 18640726
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
3. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo.
Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS
Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476
[TBL] [Abstract][Full Text] [Related]
4. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
5. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W
J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281
[TBL] [Abstract][Full Text] [Related]
6. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes.
Michel J; Schwarz H
Cytokine; 2000 Jun; 12(6):742-6. PubMed ID: 10843756
[TBL] [Abstract][Full Text] [Related]
7. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
8. Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.
Dongming L; Zuxun L; Liangjie X; Biao W; Ping Y
Clin Chim Acta; 2010 Mar; 411(5-6):406-10. PubMed ID: 20026323
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation.
Shin SM; Kim YH; Choi BK; Kwon PM; Lee HW; Kwon BS
J Leukoc Biol; 2007 Jun; 81(6):1455-65. PubMed ID: 17389581
[TBL] [Abstract][Full Text] [Related]
10. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
Lynch DH
Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
[TBL] [Abstract][Full Text] [Related]
12. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
Olofsson PS; Söderström LA; Wågsäter D; Sheikine Y; Ocaya P; Lang F; Rabu C; Chen L; Rudling M; Aukrust P; Hedin U; Paulsson-Berne G; Sirsjö A; Hansson GK
Circulation; 2008 Mar; 117(10):1292-301. PubMed ID: 18285570
[TBL] [Abstract][Full Text] [Related]
13. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
[TBL] [Abstract][Full Text] [Related]
14. Cross-linking of 4-1BB up-regulates IL-13 expression in CD8(+) T lymphocytes.
Nam KO; Shin SM; Lee HW
Cytokine; 2006 Jan; 33(2):87-94. PubMed ID: 16488622
[TBL] [Abstract][Full Text] [Related]
15. CD137 ligand signaling enhances myelopoiesis during infections.
Tang Q; Jiang D; Alonso S; Pant A; Martínez Gómez JM; Kemeny DM; Chen L; Schwarz H
Eur J Immunol; 2013 Jun; 43(6):1555-67. PubMed ID: 23519951
[TBL] [Abstract][Full Text] [Related]
16. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes.
Palazón A; Teijeira A; Martínez-Forero I; Hervás-Stubbs S; Roncal C; Peñuelas I; Dubrot J; Morales-Kastresana A; Pérez-Gracia JL; Ochoa MC; Ochoa-Callejero L; Martínez A; Luque A; Dinchuk J; Rouzaut A; Jure-Kunkel M; Melero I
Cancer Res; 2011 Feb; 71(3):801-11. PubMed ID: 21266358
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of membrane TNF-alpha on activated peripheral CD8+ T cells in systemic lupus erythematosus.
Horiuchi T; Morita C; Tsukamoto H; Mitoma H; Sawabe T; Harashima S; Kashiwagi Y; Okamura S
Int J Mol Med; 2006 May; 17(5):875-9. PubMed ID: 16596274
[TBL] [Abstract][Full Text] [Related]
18. Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling.
Jiang D; Yue PS; Drenkard D; Schwarz H
Stem Cells; 2008 Sep; 26(9):2372-81. PubMed ID: 18566330
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.
Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB
Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death.
Atsumi T; Sato M; Kamimura D; Moroi A; Iwakura Y; Betz UA; Yoshimura A; Nishihara M; Hirano T; Murakami M
Int Immunol; 2009 Jan; 21(1):73-80. PubMed ID: 19050105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
